- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Resmed Inc DRC (RMD)
Track today's live Resmed DRC (RMD) share price, performance and key data on this page with our current Sydney:RMD stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Resmed DRC share price on the Sydney exchange. Use the dropdown to switch exchange for the RMD share price, head to our technical summary section, which provides analysis on Resmed DRC share price buy/sell indicators using real-time data (or discuss the Resmed DRC (RMD) stock price today with other investors in the Resmed DRC ASX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ASX:RMD share price (ISIN: AU000000RMD6) to enhance your trading decisions with our free investment tools and resources.
What Is the Resmed Inc DRC Share Price Today?
The Resmed DRC share price today is 29.790.
What Is the Stock Symbol for Resmed Inc DRC
The stock symbol (or 'ticker') for Resmed Inc DRC is "RMD."
What Stock Exchange Does Resmed Inc DRC Trade On?
Resmed Inc DRC is listed and trades on the Sydney stock exchange.
Is Resmed Inc DRC a Good Stock to Buy?
Determining whether Resmed DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current ASX:RMD share price (ISIN: AU000000RMD6) to enhance your trading decisions with our free investment tools and resources.
What Is the Resmed Inc DRC Share Price Today?
The Resmed DRC share price today is 29.790.
What Is the Stock Symbol for Resmed Inc DRC
The stock symbol (or 'ticker') for Resmed Inc DRC is "RMD."
What Stock Exchange Does Resmed Inc DRC Trade On?
Resmed Inc DRC is listed and trades on the Sydney stock exchange.
Is Resmed Inc DRC a Good Stock to Buy?
Determining whether Resmed DRC (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
29.980
+0.190(+0.64%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.930
30.020
52 wk Range
25.500
45.250
RMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
29.93030.020
52 wk Range
25.50045.250
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.16%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
RMD Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
39.904
Upside
+33.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 14 consecutive years
Resmed inc. receives Investment Bank Analyst Rating Update- Investing.com
Pro
Resmed inc. receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
11 Buy
2 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 39.904
(+33.10% Upside)
Earnings
Latest Release
01/05/2026
EPS / Forecast
2.74 / --
Revenue / Forecast
1.43B / --
Compare RMD to Peers and Sector
Metrics to compare | RMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipRMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.0x | 24.2x | −0.3x | |
PEG Ratio | 1.22 | 0.30 | 0.00 | |
Price/Book | 4.7x | 2.1x | 2.6x | |
Price / LTM Sales | 5.5x | 1.9x | 3.0x | |
Upside (Analyst Target) | 33.5% | 0.0% | 56.3% | |
Fair Value Upside | Unlock | 12.6% | 9.2% | Unlock |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients’ device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Resmed DRC (Sydney: RMD) Share Price Today?
The Resmed DRC stock price today is 29.980 AUD.
What Stock Exchange Does Resmed DRC (RMD) Trade On?
Resmed DRC is listed and trades on the Sydney Stock Exchange.
What Is the Ticker (Stock Symbol) for Resmed DRC?
The stock symbol (also called a 'ticker') for Resmed DRC is "RMD."
Does Resmed DRC Pay Dividends? What’s The Current RMD Dividend Yield?
Yes, RMD Pays Dividends to its Shareholders. The current Resmed DRC dividend yield is 1.16%.
What Is the Current Resmed DRC Market Capitalisation?
As of today, Resmed DRC (Sydney: RMD) market cap is 43.180B AUD.
What Is Resmed DRC's (RMD) Earnings Per Share (TTM)?
The Resmed DRC EPS is currently 10.370 (Trailing Twelve Months).
Is RMD a Buy or Sell From a Technical Analyst Perspective?
Based on today's Resmed DRC moving averages and other technical indicators, the daily buy/sell signal for RMD stock is Strong Buy.
How Many Times Has Resmed DRC Stock Split?
Resmed DRC has split 3 times. (See the RMD stock split history page for full effective split date and price information.)
How Many Employees Does Resmed DRC Have?
Resmed DRC has 10600 employees, based on their latest Companies House report.
What is the current trading status of Resmed DRC (Sydney: RMD)?
As of 03/08/2026, Resmed DRC (RMD) is trading at a share price of 29.980 AUD, with a previous close of 29.790 AUD. The stock has fluctuated within a day range of 29.930 AUD to 30.020 AUD, while its 52-week range spans from 25.500 AUD to 45.250 AUD.
What Is Resmed DRC (RMD) Price Target According to Analysts?
The average 12-month price target for Resmed DRC is 39.904 AUD, with a high estimate of 46.62110209 AUD and a low estimate of 33.67364374 AUD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +33.10% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.